Drugs / YT023
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07510139 | Mar 2026 → Dec 2028 expected | primary ovarian failure | International Peace Maternity and Child Health Hospital | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YT023 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07510139 ↗ |
| Modality | Other / unclassified | “Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes” NCT07510139 ↗ |
| Route | Other | “administered via in situ (intra-ovarian) injection” NCT07510139 ↗ |